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SUMMARY.-Sequential studies on levels of glycogen and lactic acid as well as
activities of glucose-6-phosphatase, fructose-1, 6-diphosphatase aldolase,
aspartic and ornithine transcarbamylase, arginase and xanthine oxidase were
carried out in liver and tumour tissue of mice fed with 0.03% thioacetamide in
normal stock diet. It was observed that significant decreaseinglycogencontent
and activities of gluconeogenic enzymes was apparent at the age of 4 months,
i.e. 2 months after thioacetamide treatment. Alterations in the other para-
meters studied were observed later, i.e. at the age of 9 months. Maximum
changes were observed in the hepatomas, i.e. at the age of 17 months.
THIOACETAMIDE is a well known hepatocarcinogen and it is known to induce
hepatomas in Wistar strain rats (Gupta, 1956). In our laboratory we have
observed (unpublished data) that thioacetamide has a tumorigenic effect on liver
tissue in the Swiss strain of mice. Further, it seemed interesting to study pro-
gressive changes in the metabolic picture of liver tissue at different intervals after
thioacetamide feeding. These sequential studies were carried out with the view
of locating early metabolic changes which may be associated with the early
histological changes that occur on continuous feeding of the carcinogen. The
present communication reports some observations on progressive metabolic
alterations in liver tissue of thioacetamide treated and control mice at different
age periods. The parameters studied in these experiments were glycogen and
lactic acid levels, and activities of aldolase, glucose-6-phosphatase, fructose-1-6-
diphosphatase, aspartic transcarbamylase, xanthine oxidase, ornithine trans-
carbamylase and arginase.
MATERIAL AND METHODS
Eight weeks old, male Swiss strain mice, from the Animal Colony ofthe Cancer
Research Institute, Bombay, were kept on stock diet, containing 0.03% thio-
acetamide. Normal mice of identical age and sex were kept on stock diet (Rana-
dive, 1957) and served as control animals. Animals were killed at different age
periods until tumours were observed in the treated mice at the age of 17 months.
Thus treated and control mice were killed at the age of 4, 6, 9, 13 and 17 months.
Each group consisted of 6 animals.
Animals were killed by decapitation. Liver tissue was dissected out, weighed
and used for biochemical studies. In the 17-month-old group of mice, where
tumours had developed, host-liver, as well as the tumour, was used for the estima-
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piece of the tissue was blended in a Potter Elvehjem homogenizer in 0 15% KCl
solution adjusted to pH 7 for other estimations. Portions of the homogenate
were used for the determination oflactic acid content, and for the assay ofglucose-
6-phosphatase, fructose-1-6-diphosphatase, aldolase, aspartic and ornithine
transcarbamylase, xanthine oxidase and arginase activities.
In order to measure the glycogen content, one piece of liver or tumour tissue
was transferred to 30% KOH solution, digested thoroughly and glycogen pre-
cipitated by absolute alcohol. The precipitated glycogen was hydrolysed with
IN H2SO4 and then neutralized with 2N NaOH solution. Free glucose was
measured by the modified method ofNelson (1944). The content ofglycogen was
expressed in terms of ,ug. ofglucose liberated per mg. tissue. Lactic acid content
was measured colorimetrically by the method of Barker and Summerson (1941).
The content oflactic acid was expressed in terms of,tg. oflactic acid per mg. tissue.
The activity ofglucose-6-phosphatase was measured by the method ofCori and
Cori (1952). The activity of fructose-1-6-diphosphatase was measured by the
method of Pogell and McGilvery (1954). Activities of both the enzymes were
expressed in terms of,ug. ofphosphorus liberated per mg. tissue per hour. Phos-
phorus was measured by the method of Fiske and Subbarow (1925). Aldolase
activity was measured by the method of Sibley and Lehninger (1949) at pH 8-6.
Enzyme activity was measured in terms of ,ug. of triose-phosphates liberated per
hour per mg. tissue.
Aspartic transcarbamylase activity was measured by the method of Kim
and Cohen (1965). Ureidosuccinic acid, the end product of the en7yme action,
was measured colorimetrically by the method ofKoritz and Cohen (1954). Enzyme
activity was expressed in terms of ,tg. of ureidosuccinic acid formed per hour per
mg. tissue.
Xanthine oxidase activity was measured by the method ofLitwack et al (1953).
Enzyme activity was expressed in terms of,ug. of xanthine used per hour per mg.
tissue. Ornithine transcarbamylase activity was measured by the method of
Burnett and Cohen (1957). Citrulline, the end product of enzyme reaction was
measured by the method ofArchibald (1944). Enzyme activity was expressed in
terms of ,ug. of citrulline formed per hour per mg. tissue. Arginase activity was
measured by the method of Brown and Cohen (1959). Urea, the end product of
the enzyme reaction was measured by the method ofArchibald (1945). Arginase
activity was expressed in terms of ,ug. of urea formed per hour per mg. tissue.
Experimental results were subjected to statstical evaluation by " t " test for
small number of samples. Differences between means giving a probability value
(P) less than 0 05 were considered significant.
RESULTS
Table I shows the content ofglycogen and lactic acid in the liver oftreated and
untreated mice. It may be observed that the content of glycogen in mice fed
with thioacetamide decreased significantly from the age of 4 months. This gly-
cogen content remained at a low level in the later groups. In the tumour bearing
mice the host liver had low glycogen content and the tumour tissue had only trace
amount of glycogen. The lactic acid content in the liver tissue of male mice fed
thioacetamide increased significantly, from the age of 9 months onwards. In
tumour bearing groups, the host liver and the tumour tissue had higher lactic acid
content than the corresponding control group.S. V. B3HIDE
TABLEI.-Level of Glycogen and Lactic Acid in Liver and Tumour Tissue of
Swiss Mice Fed with Thioacetamide
Glycogen Lactic acid
Age , _ A ox_
(months) Tissue Control Treated Control Treated
4 . Liver . 60-53±2-8 41-81±3*
6 . Liver . 68-7±3 8 45.6+3-33* . 140-9 1-0±0-04
9 . Liver . 619±4-36 38-2±0-77* . 1-2±0-2 4-8±0-03*
13 . Liver . 35-5±5 19.6±1-3* . 1.1±0.1 3-8±0-5*
17 . Host-liver. 26- 4±0 6 1-1.±35* . 14±0*2 2.-1±004*
Tumour . - 0-28±0-04* . - 2.2±01*
Values represent mean of six readings.
* Denotes statistically significant when compared with corresponding control group and P value
is <0 05.
Content ofglycogen is expressed in terms of ,ug. of glucose per mg. tissue.
Content of lactic acid is expressed in terms ofug. of lactic acid per mg. tissue.
TABLE JI.-GlUcose-6-phosphatase and Fructose-1-6-diphosphatase Activity in Liver
and Tumour Tissue of Swiss Mice Fed with Thioacetamide
Glucose-6-phosphatase Fructose-1-6-diphosphatase
Age A
I A
(months) Tissue Control Treated Control Treated
4 . Liver . 34-4±1-1 20-4±1-4* 11-3±1.6 8.8±0.3*
6 . Liver . 29-±2-6 17-9±1-2* 10-3±0-6 7-8±0-5*
9 . Liver 32-3±1-5 23-9±2-23* 12-8±0-9 5.7±0.4*
13 . Liver . 21-4±1-8 8.4±1-2* . 8-4±0-8 4-1±0.4*
17 . Host-liver . 22 89±0 7 11-73±1-11* . 10-5±0-6 5-6±0-5*
Tumour . - 13.9±1.13* . 5.4±0.5*
Values represent mean of six readings.
* Denotes statistically significant when compared with corresponding control group and P value
is <005.
Enzyme activities are expressed in terms of,ug. ofphosphorus liberated per hour mg. tissue.
TableII summarizes the activities ofglucose-6-phosphatase and fructose-1-6-
diphosphatase in the liver tissue of control and thioacetamide treated mice. It is
evident from the table that the activities ofboth the enzymes in thioacetamide fed
mice decreased from the age of 4 months. The extent of decrease in enzyme
activities in the host liver and tumour was comparable. Moraru, Cotutiu and
Streja (1967) have reported a decrease in gluconeogenesis of short term feeding of
thioacetamide.
From Table III it is quite obvious that the thioacetamide treatment caused an
increase in the activity of aldolase in treated mice from the age of 9 months. In
TABLE III.-Aldolase Activity in Liver and Tumour Tissue of Swiss Mice
Fed with Thioacetamide
Age
(months) Tissue Control Treated
6 . Liver . O*95±0*03 . 0*81±0*085
9 . Liver . 0 9±006 . 1*3±0*10*
13 . Liver 0-65±0-05 1 88R0 05*
17 Host-liver . 0 73±0 1 . 1*66±0*083*
Tumour . 1*85±0*14*
Values represent mean of six readings.
* Denotes statistically significant when compared with corresponding control group and P value
is <0*05.
Enzyme activity is expressed in terms ofpug. oftriose-phosphatase liberated per hour per mg. tissue
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tumour bearing mice the host liver and the tumour tissue had significantly higher
enzyme activity than the corresponding control liver tissue.
TABLE IV.-Ornithine Transcarbamylase Activity in Liver and Tumour
Tissue ofThioacetamide Fed Mice
Aspartic transcarbamylase Ornithine transcarbamylase
Age A
(months) Tissue Control Treated Control Treated
6 . Liver . 5.0±0-8 6 9±0 3 . 69±0-3 4 5±0d11
9 . Liver . 5-206 8.3±0-7* 7 9±0 7 5-6±0-4
13 . Liver . 5-6±0.4 9.0±0.4* . 6-1±0-3 3.1±0-2*
17 . Host-liver . 6.6±0.1 8-5±0-1* . 7 0±0 4 3-4±0-3*
Tumour . 11.1±0.3* 4.04±0.65*
Values represent mean of six readings.
* Denotes statistical significance when compared with control group, and P values is < 0 05.
Aspartic transcarbamylase activity is expressed in terms of ,ug. of ureidosuccinic acid formed per
hour per mg. tissue.
Ornithine transcarbamylase activity is expressed in terms of pcg. of Citrulline formed per hour per
mg. tissue.
Table IV shows the activities of aspartic and ornithine transcarbamylase in
liver and tumour tissue. It is evident from the table that aspartic transcarb-
amylase activity increased from the age of 9 months, whereas ornithine trans-
carbamylase activity decreased from the age of 13 months. Maximum change in
the enzyme activities was observed in the tumour. Host liver of the tumour
bearing mice had an enzyme activity comparable with that of the tumour.
Increase in aspartic transcarbamylase activity in regenerating liver and
hepatomas was reported previously (Calva, Lowenstein and Cohen, 1959; Sapre,
Gothoskar and Bhide, 1969a), as was a decrease in ornithine transcarbamylase
activity in liver tissue of rats and mice fed with 3,2'dimethoxyaminoazobenzene
(Bhide, Kanekar and Ambaye, 1967).
TABLE V.-Arginase Activity in Liver and Tumour Tissue of
Thioacetamide Fed Mice
Xanthine oxidase Arginase
Age r -A_ -_ I A_____-
(months) Tissue Control Treated Control Treated
6 . Liver . 11±0.1 1 1±0 2 . 1136±20 1225±35
9 . Liver . 13±0-1 0-7±0-08* . 1009±25 751±31*
13 . Liver . 1i2±0-2 0-6±0-1* . 1189 ±52 677±42*
17 . Host-liver . 1-5±0 1 0-5±1.2* . 1185±32 753±43*
Tumour . 0.4±0.2* . 745±36*
Values represent mean of six readings.
* Denotes statistical significance when compared with control group and P value is <0-05.
Xanthine oxidase activity is expressed in terms of pg. of xanthine used per hour per mg. tissue.
Arginase activity is expressed in terms of ,g. of urea formed per hour per mg. tissue.
Table V shows the activities ofxanthine oxidase and arginase in thioacetamide
treated and control mice. Xanthine oxidase and arginase activity decreased
from the age of 9 months. Host-liver and tumour had comparable enzyme
activities.
DISCUSSION
From the foregoing results it is apparent that thioacetamide feeding causes
significant alterations inthe various parameters studiedin the present experiments.
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Thioacetamide feeding caused a considerable loss in glycogen content and the
activities of gluconeogenic enzymes from the age of 4 months. Decrease in
glycogen content on feeding of carcinogenic compounds has been reported by
several authors (Chang, Spain and Griffin, 1958; Orr, Price and Strickland, 1948).
It may be mentioned here that it has been reported from this laboratory that even
a single i.p. injection ofthioacetamide (50 mg./g. bodyweight), selectivelydecreases
glycogen content of the liver tissue (Sapre, Gothoskar and Bhide, 1969b). Hence
it seems probable that continuous administration of thioacetamide should affect
glycogen levels in the liver tissue of the treated mice, as early as at the age of 4
months. Furthermore it is interesting to observe that the increase in lactic acid
content and the activity of aldolase appears a little later, i.e. at the age of 9
months. Increase in lactic acid content denotes increase in glycolytic activity and
the increase in aldolase activity further supports this contention. Hence it seems
that continued significant decrease in glycogen content in liver tissue of thio-
acetamide treated mice in later age periods, may be due to stimulated glycolytic
activity of the liver tissue.
With reference to the enzymes in nucleic acid metabolism, it is interesting to
note that concurrent with the increase in aspartic transcarbamylase activity,
xanthine oxidase activity decreases. Sheth, Bhide and Ranadive (1968) have
observed that in spontaneous mammary carcinogenesis xanthine oxidase activity
in mammary tissue decreases progressively and is absent in mammary tumour.
In the present experiments we have not observed total disappearance of xanthine
oxidase activity in hepatomas and hence it appears that total deletion ofxanthine
oxidase activity is not a necessary attribute of malignancy. With reference to
enzymes of the urea cycle the present work supports the observations of Burke
(1962) and McLean, Reid and Gurney (1964). These authors have observed a
decrease in production of urea nitrogen and in the activity of urea cycle enzymes
in the livers of rats fed a carcinogenic diet.
The most interesting observation that emerges from the present experiment is
that the decrease in glycogen level and activities of gluconeogenic enzymes begin
to appear as early as the age of4 months, i.e. 2 months after starting thioacetamide
feeding. At this stage oftreatment, there were no visible changes in the morpho-
logy and histology ofthe liver (unpublished data). On the other hand alterations
in other parameters begin to appear much later, i.e. from the age of 9 months
onwards when the hepatic cells begin to show hypertrophy and even regenerating
nodules in certain areas. Itis, therefore, remarkable thatthese significant changes
in the carbohydrate metabolism appear even before the appearance of preneo-
plastic histological changes in the liver tissue. It now seems worthwhile to
explore if such early changes in the carbohydrate metabolism of liver tissue affect
the blood biochemistry as well, which may help in the early detection of possible
neoplastic changes in the target organ.
The author wishes to thank Dr. (Mrs.) K. J. Ranadive, Chief, Biology Division
for her constant encouragement in this project.
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